#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



News Economic Burden and Loss of Quality of Life as a Consequence of Dry Eye Syndrome

Canadian authors evaluated the direct and indirect financial costs associated with dry eye syndrome (DED −⁠ dry eye disease) and the impact of this condition on the quality of life (QoL) of patients. The results were stratified according to the severity of the condition. The most significant was the loss of work productivity, highlighting the need for adequate solutions for DED.
Source: Treatment of Glaucoma 1. 4. 2024

News Prof. Miloš Broďák: Introduction of new drugs has significantly improved results even in progressive and recurrent prostate cancers

The prognosis and treatment outcomes for patients with various stages of prostate cancer have significantly improved over the past two decades thanks to a number of new or improved modalities of diagnosis and therapy. We should soon benefit from newly introduced screening, or early detection programs, for these tumors. We briefly speak with Prof. MUDr. Miloš Broďák, Ph.D., head of the Urology Clinic of the Medical Faculty of Charles University and University Hospital Hradec Králové, about the latest advancements and challenges in this field, and comprehensively summarize the current options and procedures available today.
Source: Oncological Treatment 3. 4. 2024

News FDA Warns Against Self-Monitoring Glucose Using Smartwatches. What About in Czechia?

On February 21st, the U.S. Food and Drug Administration (FDA) issued a warning aimed at diabetic patients who measure their blood glucose levels (or are considering doing so) using smartwatches or rings. The warning naturally also targeted attending physicians who might encounter this method of non-invasive measurement in their patients. The Czech diabetologists we spoke to have only come across a few cases of this so far. Nevertheless, many of them believe it is necessary to discuss the topic with diabetics preventively and to actively work with those who decide to use such methods.
Source: 12. 4. 2024

News Where radical surgery cannot be performed in the subhepatic region or liver, there is room for radiation treatment

Proton radiotherapy continues to expand its indications in the treatment of oncological diseases. In the following interview, we focus on its role in treating tumors in the subhepatic region. MUDr. Pavel Vítek, Ph.D., MBA, from the Proton Center Prague (PTC), shared his perspective on this modality and his experiences at his workplace.
Source: Proton Radiotherapy 10. 4. 2024

News Artificial Intelligence Helps in Selecting Influenza Strains for Vaccine Production

Vaccination is one of the most important and effective preventive measures in the fight against seasonal epidemics caused by influenza viruses each year. For vaccines to work, they must match the currently circulating influenza strains. The timely selection of appropriate influenza strains, which will be the most widespread in the population in the upcoming period, and their yield are crucial for vaccine development. The new MAIVeSS (Machine-learning Assisted Influenza Vaccine Strain Selection) method, which uses artificial intelligence and machine learning algorithms for direct analysis of clinical samples, could help with this process.
Source: 17. 4. 2024

News Central European Expert Consensus on the Treatment of ITP in Adult Patients

In a recently published consensus, experts from Central Europe evaluate the current treatment options for immune thrombocytopenia (ITP) in adult patients and issue 7 recommendations for the administration of thrombopoietin receptor agonists (TPO-RA) in the 2nd line treatment of ITP, based on an analysis of 31 randomized controlled trials.
Source: Immune Thrombocytopenia 15. 4. 2024

News How do patients perceive the treatment of ITP with romiplostim?

Romiplostim, along with eltrombopag and avatrombopag, belongs to the group of thrombopoietin receptor agonists (TPO-RA) used in the second line of treatment for immune thrombocytopenia (ITP). Its efficacy and safety are confirmed by numerous studies, but how do patients perceive its use and to what extent does it improve their quality of life? This was the focus of a review article by authors from the American Baylor College of Medicine.
Source: Immune Thrombocytopenia 15. 4. 2024

News Under the Microscope: How is Patient Care for Heart Failure in the Czech Republic in Real Practice?

The journal Vnitřní lékařství recently published the results of a survey conducted among outpatient cardiologists and internists. The aim was to determine the level of diagnosis and treatment of patients with chronic heart failure (CHF) in real-life practice in the Czech Republic, with a special focus on the presence of symptoms in patients who have not yet been diagnosed. We briefly summarize the key findings from this survey.
Source: Heart Failure 18. 4. 2024

News Use of Medical Cannabis in Patients with Fibromyalgia to Relieve Pain and Depression

Medical cannabis is prescribed to patients with chronic pain resistant to conventional treatments. The efficacy of tetrahydrocannabinol (THC) therapy in patients with fibromyalgia syndrome (FMS) was recently evaluated in a German study.
Source: Medical Cannabis 22. 4. 2024

News What is the future of xenotransplantation? Pig liver and kidneys transplanted to humans for the first time

The initial successes of pig organ transplants to humans, conducted this March, gave hope that clinical trials of these procedures could soon become a reality. What path then leads to the clinical use of xenotransplantation?
Source: 30. 4. 2024

News New Technology Teaches Healthcare Professionals to Deliver Messages Patients Don't Want to Hear

Communication with patients and their relatives is often very challenging for doctors and nurses, especially when the patient or their family member is experiencing strong emotions. A new technology from the startup ComGuide is here to help healthcare professionals practice how to communicate most effectively. Jan Hrdlička, the co-author, explained how exactly this technology works, who it is suitable for, and how it was developed and continues to evolve.
Source: 3. 5. 2024

News Comparison of 5 Beta-Blockers in Heart Failure with Reduced Ejection Fraction

An analysis of 26 studies with beta-blockers in the treatment of heart failure with reduced ejection fraction compared 5 drugs (bisoprolol, metoprolol-succinate, metoprolol-tartrate, carvedilol, and nebivolol). The results showed a more favorable prognosis with bisoprolol compared to carvedilol, a similar effect on prognosis for carvedilol, metoprolol-succinate, and nebivolol, and the least favorable prognosis with metoprolol-tartrate.
Source: Cardiovascular Continuum 24. 4. 2024

News Over the Last 25 Years, Latanoprost Has Changed the Paradigm of Glaucoma Treatment

An important milestone in the treatment of glaucoma was the introduction of latanoprost with an entirely new mechanism of action compared to previously used antiglaucoma medications. Prostaglandin analogs (PGAs) have become the first-line treatment for primary open-angle glaucoma (POAG) primarily due to their efficacy, once-daily dosing, and minimal systemic side effects. The following recent review briefly summarizes the impact of the introduction of PGAs 25 years ago on current clinical practice in the treatment of glaucoma.
Source: Treatment of Glaucoma 7. 5. 2024

News Efficacy and Safety of Romosozumab in Postmenopausal Women with Osteoporosis and Renal Impairment

The coexistence of osteoporosis and chronic kidney disease (CKD) increases the risk of fractures and overall mortality in patients. A recent post-hoc analysis of two controlled randomized multicenter studies (FRAME and ARCH) investigated the efficacy and safety of romosozumab in postmenopausal women with osteoporosis and mild to moderate CKD.
Source: Osteoporosis – Trends in Sequential Therapy 9. 5. 2024

News CASE STUDY: Key Benefits of GLP-1RA in Diabetes Therapy in the Office of a General Practitioner

Modern therapy using glucagon-like peptide-1 receptor agonists (GLP-1RA) offers diabetics highly effective management of their primary condition as well as several other advantages: it reduces the risk of hypoglycemia, aids in weight loss, and has a positive impact on the heart and blood vessels, including increasing the chances of preventing and delaying the progression of micro and macrovascular complications. Early initiation of this treatment not only significantly improves diabetes control but also helps in preventing or delaying the development of atherosclerosis and cardiometabolic syndrome.
Source: Modern Treatment of Diabetes with GLP-1 Analogues 16. 5. 2024

1 82 83 84 85 86 667
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#